Evidence map›Paper›PMID 28887301›Full record

ArticleThe Journal of biological chemistry2017

The phospholipase PNPLA7 functions as a lysophosphatidylcholine hydrolase and interacts with lipid droplets through its catalytic domain.

Christoph Heier, Benedikt Kien, Feifei Huang, Thomas O Eichmann, Hao Xie, Rudolf Zechner, Ping-An Chang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The PNPLA family of enzymes: characterisation and biological role.Arhiv za higijenu rada i toksikologiju · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Current Knowledge on Mammalian Phospholipase AMolecules (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Christoph HeierFrom the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Benedikt KienFrom the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Feifei HuangKey Laboratory of Molecular Biology, School of Bio-information, Chongqing University of Posts and Telecommunications, Chongqing 400065, China.
Thomas O EichmannFrom the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Hao XieFrom the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Rudolf ZechnerFrom the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Ping-An ChangFrom the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria, changpingan@aliyun.com.
University of Graz · ATChongqing University of Posts and Telecommunications · CN

Funding

Austrian Science Fund FWF Z 136European Research Council 340896
6 · The paper itself

Abstract

Mammalian patatin-like phospholipase domain-containing proteins (PNPLAs) are lipid-metabolizing enzymes with essential roles in energy metabolism, skin barrier development, and brain function. A detailed annotation of enzymatic activities and structure-function relationships remains an important prerequisite to understand PNPLA functions in (patho-)physiology, for example, in disorders such as neutral lipid storage disease, non-alcoholic fatty liver disease, and neurodegenerative syndromes. In this study, we characterized the structural features controlling the subcellular localization and enzymatic activity of PNPLA7, a poorly annotated phospholipase linked to insulin signaling and energy metabolism. We show that PNPLA7 is an endoplasmic reticulum (ER) transmembrane protein that specifically promotes hydrolysis of lysophosphatidylcholine in mammalian cells. We found that transmembrane and regulatory domains in the PNPLA7 N-terminal region cooperate to regulate ER targeting but are dispensable for substrate hydrolysis. Enzymatic activity is instead mediated by the C-terminal domain, which maintains full catalytic competence even in the absence of N-terminal regions. Upon elevated fatty acid flux, the catalytic domain targets cellular lipid droplets and promotes interactions of PNPLA7 with these organelles in response to increased cAMP levels. We conclude that PNPLA7 acts as an ER-anchored lysophosphatidylcholine hydrolase that is composed of specific functional domains mediating catalytic activity, subcellular positioning, and interactions with cellular organelles. Our study provides critical structural insights into an evolutionarily conserved class of phospholipid-metabolizing enzymes.

Indexed as

AnimalsCatalytic DomainCell LineChlorocebus aethiopsCOS CellsEndoplasmic ReticulumHydrolasesLipaseLipid DropletsLysophosphatidylcholinesLysophospholipaseHydrolasesLipaseLysophosphatidylcholinesLysophospholipasePNPLA7 protein, humanendoplasmic reticulum (ER)lipid dropletlysophospholipidphospholipasephospholipid metabolismprotein domain

Identifiers

PMID28887301
PMCPMC5704489
OpenAlexW2751260325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.